Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis, and bronchiolitis obliterans

被引:59
作者
Chorzelski, T
Hashimoto, T
Maciejewska, B
Amagai, M
Anhalt, GJ
Jablonska, S
机构
[1] Warsaw Acad Med & Hosp, Dept Dermatol, PL-02008 Warsaw, Poland
[2] Warsaw Hosp MSW, Warsaw, Poland
[3] Kurume Univ, Sch Med, Dept Dermatol, Fukuoke, Japan
[4] Keio Univ, Sch Med, Dept Dermatol, Tokyo 108, Japan
[5] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21218 USA
关键词
D O I
10.1016/S0190-9622(99)70111-8
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Cases of paraneoplastic pemphigus (PNP) have been reported associated with various lymphoproliferative malignancies and benign Castleman tumors, with the most severe course and fatal outcome seen in patients with bronchiolitis obliterans. Objective: The aim was to establish immunologic associations by coexistence of Castleman tumor, myasthenia gravis, and bronchiolitis obliterans and to evaluate tht treatment modalities. Methods: Clinical studies included computed tomography of the mediastinum, computed tomograph and magnetic resonance imaging of the abdominal cavity and quantitative electromyography Direct and indirect immunofluorescence on various substrates, immunoblot analysis, immunoprecipitation. and specific enzyme-linked immunosorbent assay using recombinant desmogleins (Dsg) were performed as immunologic assays. Results: Direct and indirect immunofluorescence including rat bladder showed intercellular antibodies. Immunoblotting disclosed antibodies to envoplakin (210 kd protein) and periplakin (190 kd protein); in addition, immunoprecipitation detected antibodies to desmoplakin I (250 kd protein). Antibodies to Dsg3 (pemphigus vulgaris antigen) were detected by specific enzyme-linktd immunosorbent assay. Myasthenia gravis was controlled by drugs; however , mucocutaneous changes were not fully responsive to corticosteroids and cyclophosphamide pulses: cyclosporine, and intravenous immunoglobulins. The surgical removal of Castleman tumor did not change the course of the disease. The fatal outcome was the result of bronchiolitis obliterans that occurred after the surgery and was only transitionally controlled by plasmapheresis. Conclusion: This is the first case of paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis, and bronchiolitis obliterans. Despite a benign character of the tumor tilt: patient died, as do all patients with bronchiolitis obliterans. Massive plasmapheresis has only a transient effect. We confirmed the presence of antibodies to Dsg 3, in addition to the set of specific paraneoplastic pemphigus antibodies against various proteins of plakin family.
引用
收藏
页码:393 / 400
页数:8
相关论文
共 45 条
[1]   Antibodies against desmoglein 3 (Pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice [J].
Amagai, M ;
Nishikawa, T ;
Nousari, HC ;
Anhalt, GJ ;
Hashimoto, T .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :775-782
[2]  
Anhalt G J, 1997, Adv Dermatol, V12, P77
[3]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[4]   CASTLEMANS TUMOR AND EROSIVE LICHEN PLANUS - COINCIDENCE OR ASSOCIATION - REPORT OF A CASE [J].
ASHINOFF, R ;
COHEN, R ;
LIPKIN, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (05) :1076-1080
[5]   PARANEOPLASTIC PEMPHIGUS - A REPORT OF 3 CASES INCLUDING ONE LONG-TERM SURVIVOR [J].
CAMISA, C ;
HELM, TN ;
LIU, YC ;
VALENZUELA, R ;
ALLEN, C ;
BONA, S ;
LARRIMER, N ;
KORMAN, NJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (04) :547-553
[6]  
CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[7]  
2-4
[8]  
CHORZELSKI TP, 1995, EUR J DERMATOL, V5, P31
[9]   ATYPICAL PEMPHIGUS VULGARIS ASSOCIATED WITH ANGIO-FOLLICULAR LYMPH-NODE HYPERPLASIA (CASTLEMANS DISEASE) [J].
COULSON, IH ;
COOK, MG ;
BRUTON, J ;
PENFOLD, C .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1986, 11 (06) :656-663
[10]  
Courville P, 1997, J INVEST DERMATOL, V108, pP82